Selected article for: "longitudinal study and prospective study"

Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
  • ID: ri2w5iby_88
    Snippet: For this longitudinal prospective study, all patients with clinical evidence of Upper Airway Obstruction candidates for corrective Palatoplasty (PP) and Rhinoplasty (RP) were recruited during December 2015 and December 2016. To evaluate the HRQoL, the Spanish version of the "FETCH TM Questionnaire" was used (FETCHSV2-Q TM ). The global right ventricular function was evaluated with parameters such as the Tricuspid Annular Plane Systolic Excursion .....
    Document: For this longitudinal prospective study, all patients with clinical evidence of Upper Airway Obstruction candidates for corrective Palatoplasty (PP) and Rhinoplasty (RP) were recruited during December 2015 and December 2016. To evaluate the HRQoL, the Spanish version of the "FETCH TM Questionnaire" was used (FETCHSV2-Q TM ). The global right ventricular function was evaluated with parameters such as the Tricuspid Annular Plane Systolic Excursion "TAPSE". Because there is a curvilinear relationship between TAPSE and weight, the following correlation equation was used. TAPSE = 0.17 + 0.52 Weight 1/3 . The maximal velocity of the S' wave and E 0 early diastolic wave of the tricuspid annulus were evaluated by tissue Doppler. In addition, systolic time intervals and the Index of myocardial performance (RVIMP) were evaluated from the spectral signal of the transtricuspid and pulmonary blood flow. All patients were evaluated between 10 and 2 days before surgery and 1-6 months afterward. Student t-test and the Wilcoxon rank test were used to compare parametric and non-parametric variables, respectively. The results were considered statistically significant with a P-value < .05.

    Search related documents:
    Co phrase search for related documents
    • blood flow and diastolic wave: 1
    • blood flow and longitudinal prospective study: 1, 2, 3
    • blood flow and myocardial performance: 1, 2
    • blood flow and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
    • blood flow and rank test: 1, 2, 3
    • blood flow and right ventricular: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • blood flow and right ventricular function: 1, 2, 3
    • blood flow and systolic time: 1, 2, 3
    • blood flow and Wilcoxon rank test: 1, 2
    • clinical evidence and longitudinal prospective study: 1
    • clinical evidence and maximal velocity: 1
    • clinical evidence and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
    • clinical evidence and rank test: 1, 2, 3
    • clinical evidence and right ventricular: 1, 2, 3, 4, 5
    • clinical evidence and right ventricular function: 1
    • clinical evidence and spanish version: 1
    • correlation equation and rank test: 1, 2
    • diastolic wave and prospective study: 1
    • diastolic wave and right ventricular: 1